Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomolecules ; 1(1): 48-62, 2011 Dec 14.
Article in English | MEDLINE | ID: mdl-24970123

ABSTRACT

Glycosylation improves the solubility and stability of proteins, contributes to the structural integrity of protein functional sites, and mediates biomolecular recognition events involved in cell-cell communications and viral infections. The first step toward understanding the molecular mechanisms underlying these carbohydrate functionalities is a detailed characterization of glycan structures. Recently developed glycomic approaches have enabled comprehensive analyses of N-glycosylation profiles in a quantitative manner. However, there are only a few reports describing detailed O-glycosylation profiles primarily because of the lack of a widespread standard method to identify O-glycan structures. Here, we developed an HPLC mapping method for detailed identification of O-glycans including neutral, sialylated, and sulfated oligosaccharides. Furthermore, using this method, we were able to quantitatively identify isomeric products from an in vitro reaction catalyzed by N-acetylglucosamine-6O-sulfotransferases and obtain O-glycosylation profiles of serum IgA as a model glycoprotein.

2.
Mol Cell Proteomics ; 9(4): 719-27, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20038609

ABSTRACT

The Human Proteome Organisation Human Disease Glycomics/Proteome Initiative recently coordinated a multi-institutional study that evaluated methodologies that are widely used for defining the N-glycan content in glycoproteins. The study convincingly endorsed mass spectrometry as the technique of choice for glycomic profiling in the discovery phase of diagnostic research. The present study reports the extension of the Human Disease Glycomics/Proteome Initiative's activities to an assessment of the methodologies currently used for O-glycan analysis. Three samples of IgA1 isolated from the serum of patients with multiple myeloma were distributed to 15 laboratories worldwide for O-glycomics analysis. A variety of mass spectrometric and chromatographic procedures representative of current methodologies were used. Similar to the previous N-glycan study, the results convincingly confirmed the pre-eminent performance of MS for O-glycan profiling. Two general strategies were found to give the most reliable data, namely direct MS analysis of mixtures of permethylated reduced glycans in the positive ion mode and analysis of native reduced glycans in the negative ion mode using LC-MS approaches. In addition, mass spectrometric methodologies to analyze O-glycopeptides were also successful.


Subject(s)
Glycomics/methods , Immunoglobulin A/analysis , Metabolome , Proteomics/methods , Proteomics/organization & administration , Algorithms , Carbohydrate Sequence , Disease/etiology , Glycomics/organization & administration , Glycomics/standards , Glycoproteins/chemistry , Glycosylation , Humans , Immunoglobulin A/chemistry , Immunoglobulin A/metabolism , Models, Biological , Polysaccharides/chemistry , Proteome/analysis , Proteome/metabolism , Proteomics/standards , Societies, Scientific/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL
...